Early versus delayed postoperative radiotherapy for treatment of low-grade gliomas

Cochrane Database of Systematic Reviews

Volumn 2015, Issue 6, 2015, Pages

  Sarmiento, J Manuel ^a   Venteicher, Andrew S ^b   Patil, Chirag G ^a  

^a CEDARS SINAI MEDICAL CENTER   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ASTROBLASTOMA; ASTROCYTOMA; BRAIN BIOPSY; BRAIN SURGERY; CANCER RADIOTHERAPY; COBALT THERAPY; CONFIDENCE INTERVAL; DISEASE EXACERBATION; EARLY INTERVENTION; EXTERNAL BEAM RADIOTHERAPY; GLIOMA; HAZARD RATIO; HEADACHE; HUMAN; INTENSITY MODULATED RADIATION THERAPY; KARNOFSKY PERFORMANCE STATUS; NAUSEA; OLIGODENDROGLIOMA; OTITIS MEDIA; OUTCOME ASSESSMENT; OVERALL SURVIVAL; POSTOPERATIVE CARE; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SEIZURE; SKIN MANIFESTATION; STEREOTACTIC RADIOSURGERY; SYSTEMATIC REVIEW; THERAPY DELAY; TUMOR GROWTH; VOMITING; XANTHOASTROCYTOMA; ADVERSE EFFECTS; BIOPSY; BRAIN NEOPLASMS; DISEASE COURSE; DISEASE FREE SURVIVAL; META ANALYSIS; MORTALITY; PATHOLOGY; SEIZURES; TIME FACTOR; WATCHFUL WAITING;

BIOPSY; BRAIN NEOPLASMS; DISEASE PROGRESSION; DISEASE-FREE SURVIVAL; GLIOMA; HUMANS; POSTOPERATIVE CARE; RADIOTHERAPY; SEIZURES; TIME FACTORS; WATCHFUL WAITING;

EID: 85016649780     PISSN: 14651858     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD009229.pub2     Document Type: Review

References (73)

1. Karim ABMF, Afra D, Cornu P, Bleehan N, Schraub S, De Witte O, et al. Randomized trial on the efficacy of radiotherapy for cerebral low-grade glioma in the adult: European Organization for Research and Treatment of Cancer Study 22845 with the Medical Research Council study BRO4: an interim analysis. International Journal of Radiation Oncology, Biology, Physics 2002;52(2):316-24.
2. van den Bent MJ, Afra D, de Witte O, Ben Hassel M, Schraub S, Hoang-Xuan K, et al. Long-term efficacy of early versus delayed radiotherapy for low-grade astrocytoma and oligodendroglioma in adults: the EORTC 22845 randomised trial. Lancet 2005;366(9490):985-90.
3. Daniels TB, Brown PD, Felten SJ, Wu W, Buckner JC, Arusell RM, et al. Validation of EORTC prognostic factors for adults with low-grade glioma: A report utilizing intergroup 86-72-51. International Journal of Oncology, Biology, Physics 2011;81(1):218-24.
4. Kiebert GM, Curran D, Aaronson NK, Bolla M, Menten J, Rutten EHJM, et al. Quality of life after radiation therapy of cerebral low-grade gliomas of the adult: results of a randomised phase III trial on dose response (EORTC Trial 22844). European Journal of Cancer 1998;34(12):1902-9.
5. Prabhu RS, Won M, Shaw EG, Hu C, Brachman DG, Buckner JC, et al. Effect of the addition of chemotherapy to radiotherapy on cognitive function in patients with low-grade glioma: secondary analysis of RTOG 98-02. Journal of Clinical Oncology 2014;32(6):535-41.
6. Sahgal A, Ironside SA, Perry J, Mainprize T, Keith JL, Laperriere N, et al. Factors influencing overall survival specific to adult low-grade astrocytoma: a population-based study. Clinical Oncology 2013;25(7):394-9.
7. Shaw E, Arusell R, Scheithauer B, O'Fallon J, O'Neill B, Dinapoli R, et al. Prospective randomized trial of low- versus high-dose radiation therapy in adults with supratentorial low-grade glioma: initial report of a North Central Cancer Treatment Group/Radiation Therapy Oncology Group/Eastern Cooperative Oncology Group study. Journal of Clinical Oncology 2002;20(9):2267-76.
8. Shaw EG, Wang M, Coons SW, Brachman DG, Buckner JC, Stelzer KJ, et al. Randomized trial of radiation therapy plus procarbazine, lomustine, and vincristine chemotherapy for supratentorial adult low-grade glioma: initial results of RTOG 9802. Journal of Clinical Oncology 2012;30(25):3065-70.
9. Taphoorn MJ, Schiphorst AK, Snoek FJ, Lindeboom J, Wolbers JG, Karim AB, et al. Cognitive functions and quality of life in patients with low-grade gliomas: the impact of radiotherapy. Annals of Neurology 1994;36(1):48-54.
10. Vigliani MC, Sichez N, Poisson M, Delattre JY. A prospective study of cognitive functions following conventional radiotherapy for supratentorial gliomas in young adults: 4-year results. International Journal of Radiation Oncology, Biology, Physics 1996;35(3):527-33.
11. Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ, et al. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. Journal of the National Cancer Institute. 1993;85(5):365-76.
12. Armstrong TS, Mendoza T, Gning I, Coco C, Cohen MZ, Eriksen L, et al. Validation of the M.D. Anderson Symptom Inventory Brain Tumor Module (MDASI-BT). Journal of Neuro-oncology 2006;80(1):27-35.
13. Borenstein M, Hedges LV, Higgins JPT, Rothstein HR. Introduction to Meta-Analysis. West Sussex: John Wiley & Sons, Ltd., 2009.
14. Chaichana KL, McGirt MJ, Laterra J, Olivi A, Quiñones-Hinojosa A. Recurrence and malignant degeneration after resection of adult hemispheric low-grade gliomas. Journal of Neurosurgery 2010;112(1):10-7.
15. Chan MD, Tatter SB, Lesser G, Shaw EG. Radiation oncology in brain tumors: current approaches and clinical trials in progress. Neuroimaging Clinics of North America. 2010;20(3):401-8.
16. Chang EF, Potts MB, Keles GE, Lamborn KR, Chang SM, Barbaro NM, et al. Seizure characteristics and control following resection in 332 patients with low-grade gliomas. Journal of Neurosurgery. 2008;108(2):227-35.
17. Chang EF, Smith JS, Chang SM, Lamborn KR, Prados MD, Butowski N, et al. Preoperative prognostic classification system for hemispheric low-grade gliomas in adults. Journal of Neurosurgery 2008;109(5):817-24.
18. Claus EB, Horlacher A, Hsu L, Schwartz RB, Dello-Iacono D, Talos F, et al. Survival rates in patients with low-grade glioma after intraoperative magnetic resonance image guidance. Cancer 2005;103(6):1227-33.
19. Combs SE, Schulz-Ertner D, Thilmann C, Edler L, Debus J. Fractionated stereotactic radiation therapy in the management of primary oligodendroglioma and oligoastrocytoma. International Journal of Radiation Oncology, Biology, Physics 2005;62(3):797-802.
20. National Cancer Institute at the National Institutes of Health. Common terminology criteria for adverse events. Version 4.0. http://ctep.cancer.gov/protocolDevelopment/electronic_applications/ctc.htm 2009.
21. DeAngelis LM. Brain tumors. New England Journal of Medicine 2001;344(2):114-23.
22. Deeks JJ. Systematic reviews in health care: Systematic reviews of evaluations of diagnostic and screening tests. BMJ 2001;323(7305):157-62.
23. DerSimonian R, Laird N. Meta-analysis in clinical trials. Controlled Clinical Trials 1986;7(3):177-88.
24. Douw L, Klein M, Fagel SS, van den Heuvel J, Taphoorn MJ, Aaronson NK, et al. Cognitive and radiological effects of radiotherapy in patients with low-grade glioma: long-term follow-up. Lancet Neurology 2009;8(9):810-8.
25. Duffau H, Capelle L. Preferential brain locations of low-grade gliomas. Cancer 2004;100(12):2622-6.
26. Eastern Cooperative Oncology Group (ECOG). Phase III Randomized Study of Radiotherapy With Versus Without Temozolomide in Patients With Symptomatic or Progressive Low-Grade Gliomas. Protocol IDs: ECOG-E3F05; NCT00978458. http://www.cancer.gov/clinicaltrials/ECOG-E3F05.
27. Thomson Reuters. Endnote; http://endnote.com/. Thomson Reuters, 2014.
28. European Organization for Research and Treatment of Cancer (EORTC). Primary chemotherapy with temozolomide versus radiotherapy in patients with low-grade gliomas after stratification for genetic1p loss: A phase III study. Protocol IDs: EORTC 22033-26033; NCT00182819. http://www.eortc.be/protoc/details.asp?protocol=22033.
29. Heppner PA, Sheehan JP, Steiner LE. Gamma knife surgery for low-grade gliomas. Neurosurgery 2005;57(6):1132-9.
30. Higgins JPT, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003;327(7414):557-60.
31. Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
32. Higgins JPT, Deeks JJ (editors). Chapter 7: Selecting studies and collecting data. In: Higgins JPT, Green S (editors), Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
33. Higgins JPT, Altman DG, Sterne JAC (editors). Chapter 8: Assessing risk of bias in included studies. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
34. Jaeckle KA, Decker PA, Ballman KV, Flynn PJ, Giannini C, Scheithauer BW, et al. Transformation of low grade glioma and correlation with outcome: an NCCTG database analysis. Journal of Neuro-oncology 2011; Vol. 104, issue 1:253-9.
35. Karim AB, Maat B, Hatlevoll R, Menten J, Rutten EH, Thomas DG, et al. A randomized trial on dose-response in radiation therapy of low-grade cerebral glioma: European Organization for Research and Treatment of Cancer (EORTC) Study 22844. International Journal of Radiation Oncology, Biology, Physics 1996;36(3):549-56.
36. Karnofsky DA, Burchenal JH. Evaluation of chemotherapeutic agents. In: CM Macleod editor(s). The Clinical Evaluation of Chemotherapeutic Agents in Cancer. New York: Columbia University Press, 1949:191-205.
37. Karnofsky DA, Burchenal JH, Armistead GC Jr, Southam CM, Bernstein JL, Craver LF, et al. Triethylene melamine in the treatment of neoplastic disease; a compound with nitrogen-mustardlike activity suitable for oral and intravenous use. Archives of Internal Medicine 1951;87(4):477-516.
38. Keles GE, Lamborn KR, Berger MS. Low-grade hemispheric gliomas in adults: a critical review of extent of resection as a factor influencing outcome. Journal of Neurosurgery 2001;95(5):735-45.
39. Kim JH, Brown SL, Jenrow KA, Ryu S. Mechanisms of radiation-induced brain toxicity and implications for future clinical trials. Journal of Neuro-oncology 2008;87(3):279-86.
40. Lote K, Egeland T, Hager B, Stenwig B, Skullerud K, Berg-Johnsen J, et al. Survival, prognostic factors, and therapeutic efficacy in low-grade glioma: a retrospective study in 379 patients. Journal of Clinical Oncology 1997;15(9):3129-40.
41. Louis DN, Ohgaki H, Wiestler OD, Cavenee WK. WHO Classification of Tumours of the Central Nervous System. 4th Edition. Vol. 1, Geneva: WHO Press, 2007.
42. McGirt MJ, Chaichana KL, Attenello FJ, Weingart JD, Than K, Burger PC, et al. Extent of surgical resection is independently associated with survival in patients with hemispheric infiltrating low-grade gliomas. Neurosurgery 2008;63(4):700-7.
43. MRC Working Party on Misonidazole in Gliomas. A study of the effect of misonidazole in conjunction with radiotherapy for the treatment of grades 3 and 4 astrocytomas. A report from the MRC Working Party on misonidazole in gliomas. British Journal of Radiology 1983;56(669):673-82.
44. Ohgaki H, Kleihues P. Population-based studies on incidence, survival rates, and genetic alterations in astrocytic and oligodendroglial gliomas. Journal of Neuropathology and Experimental Neurology 2005;64(6):479-89.
45. Ostrom QT, Gittleman H, Liao P, Rouse C, Chen Y, Dowling J, Wolinsky Y, Kruchko C, Barnholtz-Sloan JS. CBTRUS Statistical Report: Primary Brain and Central Nervous System Tumors Diagnosed in the United States 2007-2011. Neuro Oncol 2014; Vol. 14, issue suppl 4:iv1-iv3.
46. Parmar MK, Torri V, Stewart L. Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints. Statistics in Medicine 1998;17(24):2815-34.
47. Pignatti F, van den Bent M, Curran D, Debruyne C, Sylvester R, Therasse P, et al. European Organization for Research and Treatment of Cancer Brain Tumor Cooperative Group, European Organization for Research and Treatment of Cancer Radiotherapy Cooperative Group. Prognostic factors for survival in adult patients with cerebral low-grade glioma. Journal of Clinical Oncology 2002;20(8):2076-84.
48. Plathow C, Schulz-Ertner D, Thilman C, Zuna I, Lichy M, Weber MA, et al. Fractionated stereotactic radiotherapy in low-grade astrocytomas: long-term outcome and prognostic factors. International Journal of Radiation Oncology, Biology, Physics 2003;57(4):996-1003.
49. Quinn JA, Reardon DA, Friedman AH, Rich JN, Sampson JH, Provenzale JM, et al. Phase II trial of temozolomide in patients with progressive low-grade glioma. Journal of Clinical Oncology 2003;21(4):646-51.
50. Surveillence of Rare Cancers in Europe. RARECARE database. http://www.rarecare.eu (accessed 26 June 2011).
51. The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). 5.3. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2014.
52. Rogers LR, Morris HH, Lupica K. Effect of cranial irradiation on seizure frequency in adults with low-grade astrocytoma and medically intractable epilepsy. Neurology 1993;43(8):1599-1601.
53. Radiation Therapy Oncology Group (RTOG). Phase II study of temozolomide and radiotherapy followed by temozolomide alone in patients with high-risk low-grade gliomas. Protocol IDs: RTOG-0424; NCT00114140. http://cancer.gov/clinicaltrials/RTOG-0424.
54. Rudà R, Bello L, Duffau H, Soffietti R. Seizure in low-grade gliomas: natural history, pathogenesis, and outcome after treatments. Neuro-oncology 2012;14(Suppl 4):iv55-64.
55. Rudà R, Magliola U, Bertero L, Trevisan E, Bosa C, Mantovani C, et al. Seizure control following radiotherapy in patients with diffuse gliomas: a retrospective study. Neuro-oncology 2013;15(12):1739-49.
56. Sanai N, Berger MS. Glioma extent of resection and its impact on patient outcome. Neurosurgery 2008;62(4):753-64.
57. Scerrati M, Roselli R, Iacoangeli M, Pompucci A, Rossi GF. Prognostic factors in low grade (WHO grade II) gliomas of the cerebral hemispheres: the role of surgery. Journal of Neurology, Neurosurgery, and Psychiatry 1996;61(3):291-6.
58. Schiff D, Brown PD, Giannini C. Outcome in adult low-grade glioma: the impact of prognostic factors and treatment. Neurology 2007;69(13):1366-73.
59. Schomas DA, Laack NN, Rao RD, Meyer FB, Shaw EG, O'Neill BP, et al. Intracranial low-grade gliomas in adults: 30-year experience with long-term follow-up at Mayo Clinic. Neuro-oncology 2009;11(4):437-45.
60. Shaw EG, Scheithauer BW, O'Fallon JR. Supratentorial gliomas: a comparative study by grade and histologic type. Journal of Neuro-oncology 1997;31(3):273-8.
61. Smith JS, Chang EF, Lamborn KR, Chang SM, Prados MD, Cha S, et al. Role of extent of resection in the long-term outcome of low-grade hemispheric gliomas. Journal of Clinical Oncology 2008;26(8):1338-45.
62. Soffietti R, Baumert BG, Bello L, von Deimling A, Duffau H, Frénay M, et al. Guidelines on management of low-grade gliomas: report of an EFNS-EANO Task Force. European Journal of Neurology 2010;17(9):1124-33.
63. Surma-aho O, Niemelä M, Vilkki J, Kouri M, Brander A, Salonen O, et al. Adverse long-term effects of brain radiotherapy in adult low-grade glioma patients. Neurology 2001;56(10):1285-90.
64. Taphoorn MJ, Claassens L, Aaronson NK, Coens C, Mauer M, Osoba D, et al. EORTC Quality of Life Group, and Brain Cancer, NCIC and Radiotherapy Groups. An international validation study of the EORTC brain cancer module (EORTC QLQ-BN20) for assessing health-related quality of life and symptoms in brain cancer patients. European Journal of Cancer 2010;46(6):1033-40.
65. van den Bent M, Wefel JS, Schiff D, Taphoorn M, Jaeckle K, Junck L, et al. Response assessment in neuro-oncology (a report of the RANO group): assessment of outcome in trials of diffuse low-grade gliomas. Lancet Oncology 2011;12(6):583-93.
66. van Veelen ML, Avezaat CJ, Kros JM, van Putten W, Vecht C. Supratentorial low grade astrocytoma: prognostic factors, dedifferentiation, and the issue of early versus late surgery. Journal of Neurology, Neurosurgery, and Psychiatry 1998;64(5):581-7.
67. Wang LW, Shiau CY, Chung WY, Wu HM, Guo WY, Liu KD, et al. Gamma Knife surgery for low-grade astrocytomas: evaluation of long-term outcome based on a 10-year experience. Journal of Neurosurgery 2006;105(Suppl):127-32.
68. Warnke PC, Berlis A, Weyerbrock A, Ostertag CB. Significant reduction of seizure incidence and increase of benzodiazepine receptor density after interstitial radiosurgery in low-grade gliomas. Acta Neurochirurgica. Supplement 1997;68:90-2.
69. Weitzner MA, Meyers CA, Gelke CK, Byrne KS, Cella DF, Levin VA. The Functional Assessment of Cancer Therapy (FACT) scale. Development of a brain subscale and revalidation of the general version (FACT-G) in patients with primary brain tumors. Cancer 1995;75(5):1151-61.
70. Wen PY, Macdonald DR, Reardon DA, Cloughesy TF, Sorensen AG, Galanis E, et al. Updated response assessment criteria for high-grade gliomas: response assessment in neuro-oncology working group. Journal of Clinical Oncology 2010;28(11):1963-72.
71. Yeh SA, Ho JT, Lui CC, Huang YJ, Hsiung CY, Huang EY. Treatment outcomes and prognostic factors in patients with supratentorial low-grade gliomas. British Journal of Radiology 2005;78(927):230-5.
72. Zubrod CG, Schneiderman M, Frei E III, Brindley C, Gold GL, Shnider B, et al. Appraisal of methods for the study of chemotherapy of cancer in man: Comparative therapeutic trial of nitrogen mustard and triethylene thiophosphoramide. Journal of Chronic Diseases 1960;11(1):7-33.
73. Venteicher AS, Patil CG. Early versus delayed radiotherapy for the treatment of low-grade gliomas. Cochrane Database of Systematic Reviews 2011, Issue 7. [DOI: 10.1002/14651858.CD009229]